Data / Form D filings / ProActa Inc
ProActa Inc: Form D filings
ProActa Inc, a biotechnology company in La Jolla, CA, filed 3 Form D notices with the SEC between 2010 and 2011. The latest, on December 23, 2011, reports $500,000 sold of a $3 million offering to 4 investors.
Find out what ProActa Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4275 EXECUTIVE SQUARE, SUITE 440, La Jolla, CA, 92037
- Phone
- (858) 642-0386
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1297823
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2011 | New notice | $3,000,000 | $500,000 | $2,500,000 | 4 | Dec 15, 2011 | sec.gov |
| Jul 7, 2010 | Amendment | $3,000,445 | $3,000,445 | $0 | 9 | Feb 8, 2010 | sec.gov |
| Feb 19, 2010 | New notice | $1,100,163 | $1,100,163 | $0 | 9 | Feb 8, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David C. Mack | Director | |
| Brigitte C. Smith | Director | |
| George C. Morstyn | Director | |
| John C. Gutheil | Executive Officer, Director | |
| John C. Villiger | Director | |
| Kevin C. de la Torre | Executive Officer | |
| Dennis C. Henner | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Dec 19, 2011 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ProActa Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.